Antisense oligonucleotides as therapeutic agents

Angela Alama, Federica Barbieri, Monica Cagnoli, Gennaro Schettini

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

The potential for modulating gene expression by the use of antisense oligonucleotides has become increasingly interesting in recent years. Antisense oligonucleotides are complementary nucleic acid fragments that hybridize to target sequences within RNA to form a DNA-RNA duplex, resulting in the block of translation of messenger RNA into the protein. Advances in chemistry and molecular biology have provided the basis to develop antisense oligodeoxynucleotides and improve their selectivity, stability and specificity of action. The antisense technology has been extensively used in vitro and in vivo as a tool to study the regulatory mechanisms in biologic processes and as potential therapeutic agents in cancer, viral infections and genetic disorders. In the present review, the various approaches for the use of antisense molecules in oncology, virology, genetic and inflammatory diseases are described; several studies, supporting the in vitro and in vivo applications of this technology, are also presented. Moreover, the potential clinical use of antisense therapies is discussed.

Original languageEnglish
Pages (from-to)171-178
Number of pages8
JournalPharmacological Research
Volume36
Issue number3
DOIs
Publication statusPublished - Sep 1997

Fingerprint

Inborn Genetic Diseases
Antisense Oligonucleotides
Technology
Virology
Oligodeoxyribonucleotides
Virus Diseases
Nucleic Acids
Molecular Biology
RNA
Gene Expression
Messenger RNA
DNA
Therapeutics
Neoplasms
Proteins
In Vitro Techniques

Keywords

  • Antisense oligonucleotides
  • Gene expression
  • Oncogenes
  • Viral targets

ASJC Scopus subject areas

  • Pharmacology

Cite this

Antisense oligonucleotides as therapeutic agents. / Alama, Angela; Barbieri, Federica; Cagnoli, Monica; Schettini, Gennaro.

In: Pharmacological Research, Vol. 36, No. 3, 09.1997, p. 171-178.

Research output: Contribution to journalArticle

Alama, A, Barbieri, F, Cagnoli, M & Schettini, G 1997, 'Antisense oligonucleotides as therapeutic agents', Pharmacological Research, vol. 36, no. 3, pp. 171-178. https://doi.org/10.1006/phrs.1997.0227
Alama, Angela ; Barbieri, Federica ; Cagnoli, Monica ; Schettini, Gennaro. / Antisense oligonucleotides as therapeutic agents. In: Pharmacological Research. 1997 ; Vol. 36, No. 3. pp. 171-178.
@article{73cd6741e2ef4572810b04b4ac46c917,
title = "Antisense oligonucleotides as therapeutic agents",
abstract = "The potential for modulating gene expression by the use of antisense oligonucleotides has become increasingly interesting in recent years. Antisense oligonucleotides are complementary nucleic acid fragments that hybridize to target sequences within RNA to form a DNA-RNA duplex, resulting in the block of translation of messenger RNA into the protein. Advances in chemistry and molecular biology have provided the basis to develop antisense oligodeoxynucleotides and improve their selectivity, stability and specificity of action. The antisense technology has been extensively used in vitro and in vivo as a tool to study the regulatory mechanisms in biologic processes and as potential therapeutic agents in cancer, viral infections and genetic disorders. In the present review, the various approaches for the use of antisense molecules in oncology, virology, genetic and inflammatory diseases are described; several studies, supporting the in vitro and in vivo applications of this technology, are also presented. Moreover, the potential clinical use of antisense therapies is discussed.",
keywords = "Antisense oligonucleotides, Gene expression, Oncogenes, Viral targets",
author = "Angela Alama and Federica Barbieri and Monica Cagnoli and Gennaro Schettini",
year = "1997",
month = "9",
doi = "10.1006/phrs.1997.0227",
language = "English",
volume = "36",
pages = "171--178",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
number = "3",

}

TY - JOUR

T1 - Antisense oligonucleotides as therapeutic agents

AU - Alama, Angela

AU - Barbieri, Federica

AU - Cagnoli, Monica

AU - Schettini, Gennaro

PY - 1997/9

Y1 - 1997/9

N2 - The potential for modulating gene expression by the use of antisense oligonucleotides has become increasingly interesting in recent years. Antisense oligonucleotides are complementary nucleic acid fragments that hybridize to target sequences within RNA to form a DNA-RNA duplex, resulting in the block of translation of messenger RNA into the protein. Advances in chemistry and molecular biology have provided the basis to develop antisense oligodeoxynucleotides and improve their selectivity, stability and specificity of action. The antisense technology has been extensively used in vitro and in vivo as a tool to study the regulatory mechanisms in biologic processes and as potential therapeutic agents in cancer, viral infections and genetic disorders. In the present review, the various approaches for the use of antisense molecules in oncology, virology, genetic and inflammatory diseases are described; several studies, supporting the in vitro and in vivo applications of this technology, are also presented. Moreover, the potential clinical use of antisense therapies is discussed.

AB - The potential for modulating gene expression by the use of antisense oligonucleotides has become increasingly interesting in recent years. Antisense oligonucleotides are complementary nucleic acid fragments that hybridize to target sequences within RNA to form a DNA-RNA duplex, resulting in the block of translation of messenger RNA into the protein. Advances in chemistry and molecular biology have provided the basis to develop antisense oligodeoxynucleotides and improve their selectivity, stability and specificity of action. The antisense technology has been extensively used in vitro and in vivo as a tool to study the regulatory mechanisms in biologic processes and as potential therapeutic agents in cancer, viral infections and genetic disorders. In the present review, the various approaches for the use of antisense molecules in oncology, virology, genetic and inflammatory diseases are described; several studies, supporting the in vitro and in vivo applications of this technology, are also presented. Moreover, the potential clinical use of antisense therapies is discussed.

KW - Antisense oligonucleotides

KW - Gene expression

KW - Oncogenes

KW - Viral targets

UR - http://www.scopus.com/inward/record.url?scp=0031234479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031234479&partnerID=8YFLogxK

U2 - 10.1006/phrs.1997.0227

DO - 10.1006/phrs.1997.0227

M3 - Article

C2 - 9367660

AN - SCOPUS:0031234479

VL - 36

SP - 171

EP - 178

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

IS - 3

ER -